glp 1 mecanismo de accion Efectos los fármacos con acción GLP-1 sobre las comorbilidades o enfermedades relacionadas con obesidad Fármacos basados en GLP-1: mecanismos

PMID: 37841843 Research Square Preprint2023 Aug 10

Excess ROS activates inflammasome pathways, including NLRP3 inflammasome, promoting pyroptosis, an inflammatory form of cell death (Fig

Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major

Common side effects include nausea, diarrhea, constipation, vomiting, and injection site reactions

Summary: Researchers unmasked a slight, statistically measurable increase in the risk of developing a rare, potentially permanent blinding condition known as ischemic optic neuropathy (a sudden restriction of blood flow to the optic nerve) among patients initiating GLP-1 therapy compared to standard diabetes regimens

Moulton CD, Pickup JC, Amiel SA, Winkley K, Ismail K